A Clinical Trial of PRAX-944 in Participants With Essential Tremor

NCT05021978 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Tremor

Interventions

DRUG: Part A: 20 and 40 mg PRAX-944
DRUG: Part B: 120 mg PRAX-944
DRUG: Part B: 120 mg PRAX-944 and Placebo

Sponsor

Praxis Precision Medicines